Masimo (MASI) Income from Non-Controlling Interests (2009 - 2016)
Masimo's (MASI) quarterly Income from Non-Controlling Interests came in at $2.8 million in Q4 2016, up 189.35% year-on-year from $951095.2 in Q1 2016, and up 189.35% quarter-over-quarter from -$3.1 million in Q1 2016.
Masimo (MASI) Income from Non-Controlling Interests (2009 - 2016) Analysis & Trends
Masimo's Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at $2.8 million for Q4 2016.
- On a quarterly basis, Income from Non-Controlling Interests rose 189.35% year-over-year to $2.8 million in Q4 2016; TTM through Dec 2016 was $2.8 million, a 147.19% increase from a year earlier, with the FY2021 full-year figure at -$20000.0, changed N/A from the prior year.
- Income from Non-Controlling Interests grew to $2.8 million in Q4 2016 per MASI's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $2.8 million in Q4 2016 and bottomed at -$3.1 million in Q1 2016.
- The 5-year median for Income from Non-Controlling Interests is -$122000.0 (2013), against an average of -$282000.0.
- Across the five-year window, Income from Non-Controlling Interests tumbled 4520.0% in 2012 and surged 1195.69% in 2014, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at -$166000.0 in 2012, then advanced by 22.89% to -$128000.0 in 2013, then soared by 1092.97% to $1.3 million in 2014, then sank by 209.83% to -$1.4 million in 2015, then surged by 297.13% to $2.8 million in 2016.
- Per Business Quant, the three latest MASI Income from Non-Controlling Interests figures stand at $2.8 million (Q4 2016), -$3.1 million (Q1 2016), and -$1.4 million (Q4 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 2.75 Mn |
| Jan 2, 2016 | -3.08 Mn |
| Oct 3, 2015 | -1.40 Mn |
| Jul 4, 2015 | -655,000.00 |
| Apr 4, 2015 | -701,000.00 |
| Sep 27, 2014 | 1.27 Mn |
| Jun 28, 2014 | 150,000.00 |
| Mar 29, 2014 | 141,000.00 |
| Dec 28, 2013 | -128,000.00 |
| Sep 28, 2013 | -116,000.00 |
| Jun 29, 2013 | -2.39 Mn |
| Mar 30, 2013 | -26,000.00 |
| Dec 29, 2012 | -166,000.00 |
| Sep 29, 2012 | -231,000.00 |
| Jun 30, 2012 | 71,000.00 |
| Mar 31, 2012 | -8,000.00 |
| Dec 31, 2011 | 346,000.00 |
| Oct 1, 2011 | -5,000.00 |
| Jul 2, 2011 | -129,000.00 |
| Apr 2, 2011 | 141,000.00 |